{"entity":{"type":"insider","cik":"0001727794","url":"/insider/0001727794","json_url":"/insider/0001727794.json","name":"Domzalski David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":13,"first":"2018-03-05","last":"2020-09-08","span_basis":"filed_date"},"name_variants":[{"name":"Domzalski David","source":"filing","n_filings":13,"first_seen":"2018-03-05","last_seen":"2020-09-08"}],"transactions":[{"id":2145379,"accession":"0001209191-20-049795","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-049795","line_url":"/filing/0001209191-20-049795#line-1","is_derivative":false,"issuer_cik":"0001566044","issuer_name":"VYNE Therapeutics Inc.","issuer_ticker":"VYNE","issuer_name_source":null,"issuer_url":"/issuer/0001566044","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":1.3809,"price_display":"1.38","price_state":"stated","total_value":103567.5,"total_display":"103,567.50","total_whole":"103,568","shares_owned_after":1315966.0,"shares_owned_after_display":"1,315,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-08","scope":"insider"},{"id":8027410,"accession":"0001209191-19-041107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-041107","line_url":"/filing/0001209191-19-041107#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3355.0,"shares_display":"3,355","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":7884.25,"total_display":"7,884.25","total_whole":"7,884","shares_owned_after":211240.0,"shares_owned_after_display":"211,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-03","scope":"insider"},{"id":8486678,"accession":"0001209191-19-023182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-023182","line_url":"/filing/0001209191-19-023182#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5096.0,"shares_display":"5,096","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":19110.0,"total_display":"19,110.00","total_whole":"19,110","shares_owned_after":214595.0,"shares_owned_after_display":"214,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-03","scope":"insider"},{"id":6789511,"accession":"0001178913-18-003091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-003091","line_url":"/filing/0001178913-18-003091#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68.0,"shares_display":"68","price_per_share":4.05,"price_display":"4.05","price_state":"stated","total_value":275.4,"total_display":"275.40","total_whole":"275","shares_owned_after":146409.0,"shares_owned_after_display":"146,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6629030,"accession":"0001178913-18-003004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-003004","line_url":"/filing/0001178913-18-003004#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5036.0,"shares_display":"5,036","price_per_share":3.9,"price_display":"3.90","price_state":"stated","total_value":19640.4,"total_display":"19,640.40","total_whole":"19,640","shares_owned_after":146477.0,"shares_owned_after_display":"146,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-19","filed_date":"2018-11-20","scope":"insider"},{"id":5985432,"accession":"0001178913-18-002897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-002897","line_url":"/filing/0001178913-18-002897#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2062.0,"shares_display":"2,062","price_per_share":4.58,"price_display":"4.58","price_state":"stated","total_value":9443.96,"total_display":"9,443.96","total_whole":"9,444","shares_owned_after":151513.0,"shares_owned_after_display":"151,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-08","filed_date":"2018-11-13","scope":"insider"},{"id":6037003,"accession":"0001178913-18-002609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-002609","line_url":"/filing/0001178913-18-002609#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":601.0,"shares_display":"601","price_per_share":5.81,"price_display":"5.81","price_state":"stated","total_value":3491.81,"total_display":"3,491.81","total_whole":"3,492","shares_owned_after":153575.0,"shares_owned_after_display":"153,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-02","scope":"insider"},{"id":6814007,"accession":"0001178913-18-002498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-002498","line_url":"/filing/0001178913-18-002498#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67.0,"shares_display":"67","price_per_share":5.67,"price_display":"5.67","price_state":"stated","total_value":379.89,"total_display":"379.89","total_whole":"380","shares_owned_after":154176.0,"shares_owned_after_display":"154,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":6545081,"accession":"0001178913-18-002365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-002365","line_url":"/filing/0001178913-18-002365#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8238.0,"shares_display":"8,238","price_per_share":5.68,"price_display":"5.68","price_state":"stated","total_value":46791.84,"total_display":"46,791.84","total_whole":"46,792","shares_owned_after":154243.0,"shares_owned_after_display":"154,243","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-08","filed_date":"2018-08-09","scope":"insider"},{"id":6252226,"accession":"0001178913-18-002034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-002034","line_url":"/filing/0001178913-18-002034#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":602.0,"shares_display":"602","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":3070.2,"total_display":"3,070.20","total_whole":"3,070","shares_owned_after":162481.0,"shares_owned_after_display":"162,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-03","scope":"insider"},{"id":6412193,"accession":"0001178913-18-001847","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-001847","line_url":"/filing/0001178913-18-001847#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67.0,"shares_display":"67","price_per_share":5.26,"price_display":"5.26","price_state":"stated","total_value":352.42,"total_display":"352.42","total_whole":"352","shares_owned_after":163083.0,"shares_owned_after_display":"163,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-04","scope":"insider"},{"id":6655150,"accession":"0001178913-18-001110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-001110","line_url":"/filing/0001178913-18-001110#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":602.0,"shares_display":"602","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":3058.16,"total_display":"3,058.16","total_whole":"3,058","shares_owned_after":139754.0,"shares_owned_after_display":"139,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-04","scope":"insider"},{"id":6892985,"accession":"0001178913-18-000759","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-000759","line_url":"/filing/0001178913-18-000759#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727794","owner_name":"Domzalski David","owner_display_name":"Domzalski David","owner_url":"/insider/0001727794","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66.0,"shares_display":"66","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":392.7,"total_display":"392.70","total_whole":"393","shares_owned_after":140356.0,"shares_owned_after_display":"140,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001566044","name":"VYNE Therapeutics Inc.","url":"/issuer/0001566044","role":"Director, Officer (President and CEO)","n_filings":1,"first_seen":"2020-09-08","last_seen":"2020-09-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001606645","name":"Foamix Pharmaceuticals Ltd.","url":"/issuer/0001606645","role":"Director, Officer (CEO)","n_filings":12,"first_seen":"2018-03-05","last_seen":"2019-07-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001727794","retrieved_at":"2026-08-23T06:58:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}